CN101943699B - 一种检测唾液中hiv抗体的试纸条及其制备方法 - Google Patents
一种检测唾液中hiv抗体的试纸条及其制备方法 Download PDFInfo
- Publication number
- CN101943699B CN101943699B CN201010270359.2A CN201010270359A CN101943699B CN 101943699 B CN101943699 B CN 101943699B CN 201010270359 A CN201010270359 A CN 201010270359A CN 101943699 B CN101943699 B CN 101943699B
- Authority
- CN
- China
- Prior art keywords
- igg antibody
- antibody
- avidin
- hiv
- biotin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 51
- 238000001514 detection method Methods 0.000 claims abstract description 44
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 34
- 230000003321 amplification Effects 0.000 claims abstract description 24
- 239000000427 antigen Substances 0.000 claims abstract description 24
- 102000036639 antigens Human genes 0.000 claims abstract description 24
- 108091007433 antigens Proteins 0.000 claims abstract description 24
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 24
- 241000283707 Capra Species 0.000 claims abstract description 18
- 229960002685 biotin Drugs 0.000 claims abstract description 17
- 239000011616 biotin Substances 0.000 claims abstract description 17
- 241000283973 Oryctolagus cuniculus Species 0.000 claims abstract description 15
- 239000002245 particle Substances 0.000 claims abstract description 14
- 239000000084 colloidal system Substances 0.000 claims description 44
- 239000010931 gold Substances 0.000 claims description 44
- 229910052737 gold Inorganic materials 0.000 claims description 44
- 210000003296 saliva Anatomy 0.000 claims description 37
- 239000000020 Nitrocellulose Substances 0.000 claims description 29
- 239000012528 membrane Substances 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 26
- 239000003365 glass fiber Substances 0.000 claims description 25
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 24
- 108090001008 Avidin Proteins 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 15
- 235000020958 biotin Nutrition 0.000 claims description 12
- 230000006287 biotinylation Effects 0.000 claims description 11
- 238000007413 biotinylation Methods 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 238000010790 dilution Methods 0.000 claims description 10
- 239000012895 dilution Substances 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 101800000385 Transmembrane protein Proteins 0.000 claims description 7
- 101800001690 Transmembrane protein gp41 Proteins 0.000 claims description 7
- 238000013016 damping Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 238000007796 conventional method Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 150000001718 carbodiimides Chemical class 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 239000002131 composite material Substances 0.000 abstract description 2
- 239000011152 fibreglass Substances 0.000 abstract 4
- 230000002745 absorbent Effects 0.000 abstract 3
- 239000002250 absorbent Substances 0.000 abstract 3
- 239000003550 marker Substances 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 74
- 239000000523 sample Substances 0.000 description 37
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 23
- 210000004379 membrane Anatomy 0.000 description 20
- 208000030507 AIDS Diseases 0.000 description 15
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 238000002965 ELISA Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 230000036039 immunity Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- -1 salt ion Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000009871 tenuigenin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000005570 vertical transmission Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010270359.2A CN101943699B (zh) | 2010-08-31 | 2010-08-31 | 一种检测唾液中hiv抗体的试纸条及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010270359.2A CN101943699B (zh) | 2010-08-31 | 2010-08-31 | 一种检测唾液中hiv抗体的试纸条及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101943699A CN101943699A (zh) | 2011-01-12 |
CN101943699B true CN101943699B (zh) | 2013-04-03 |
Family
ID=43435799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010270359.2A Active CN101943699B (zh) | 2010-08-31 | 2010-08-31 | 一种检测唾液中hiv抗体的试纸条及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101943699B (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102680690B (zh) * | 2011-03-17 | 2015-02-25 | 北京易斯威特生物医学科技有限公司 | 第四代hiv抗体抗原检测试纸 |
CN102841207A (zh) * | 2011-06-24 | 2012-12-26 | 北京乐普医疗科技有限责任公司 | 定量检测肌钙蛋白i的荧光免疫层析试纸条及其制备方法 |
CN102445537A (zh) * | 2011-12-20 | 2012-05-09 | 广州万孚生物技术有限公司 | 一种甲型流感病毒抗原和乙型病毒流感抗原的联检试纸及其制备方法 |
CN102539755A (zh) * | 2011-12-20 | 2012-07-04 | 广州万孚生物技术有限公司 | 一种检测分泌物中甲型流感病毒抗原的试纸条及其制备方法 |
TWI493042B (zh) * | 2012-03-05 | 2015-07-21 | Sudx Life Science Corp | 自唾液檢體檢測hiv-1之早期檢測方法及其聚糖固定化金屬奈米粒子 |
CN102768277B (zh) * | 2012-07-25 | 2014-05-07 | 成都协和生物技术有限责任公司 | 口腔黏膜渗出液胶体金法检测hiv抗体的样本稀释液及其制备方法 |
CN103675271B (zh) * | 2013-12-23 | 2016-01-06 | 北京新华联协和药业有限责任公司 | 过敏性疾病变应原胶体金诊断试纸条及其制备方法 |
CN104297482B (zh) * | 2014-09-16 | 2016-08-17 | 中山生物工程有限公司 | EB病毒VCA/NA1-IgA抗体联合检测试剂及其制备方法 |
CN105137081A (zh) * | 2015-04-28 | 2015-12-09 | 南京农业大学 | 一种基于单克隆抗体的吡虫啉检测试纸条 |
CN106290832A (zh) * | 2016-08-12 | 2017-01-04 | 上海铭源数康生物芯片有限公司 | 一种免疫侧向层析定量检测试剂及其制备方法、检测方法 |
CN106970219A (zh) * | 2017-04-28 | 2017-07-21 | 北京金豪制药股份有限公司 | 一种基于胶体金法检测尿液中hiv(1+2)抗体试剂 |
CN108196050A (zh) * | 2018-02-02 | 2018-06-22 | 江苏维尔生物科技有限公司 | 用于检测唾液中人类免疫缺陷病毒抗体和梅毒螺旋体抗体的胶体金试纸及其制备和使用方法 |
CN108490171A (zh) * | 2018-03-02 | 2018-09-04 | 北京库尔科技有限公司 | 一种高灵敏唾液抗体检测试剂盒 |
JP7241619B2 (ja) * | 2019-06-19 | 2023-03-17 | アークレイ株式会社 | 標的物質検出方法、標的物質検出キット、標的物質検出システム |
CN111273004B (zh) * | 2020-03-09 | 2024-01-19 | 北京华晟源医疗科技有限公司 | 一种基于胶体金法检测尿液中HIV(l+2)抗体试剂条及其制备方法 |
CN113341138A (zh) * | 2021-05-21 | 2021-09-03 | 长沙兴嘉生物工程股份有限公司 | 一种同时检测ASFV特异性IgM和IgG抗体的联合检测卡及其制备方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101495865A (zh) * | 2005-05-20 | 2009-07-29 | 克利普特生物医药公司 | 口腔流体快速免疫层析检测 |
-
2010
- 2010-08-31 CN CN201010270359.2A patent/CN101943699B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101495865A (zh) * | 2005-05-20 | 2009-07-29 | 克利普特生物医药公司 | 口腔流体快速免疫层析检测 |
Also Published As
Publication number | Publication date |
---|---|
CN101943699A (zh) | 2011-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101943699B (zh) | 一种检测唾液中hiv抗体的试纸条及其制备方法 | |
CN108254550B (zh) | 检测ck-mb的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法 | |
CN102445537A (zh) | 一种甲型流感病毒抗原和乙型病毒流感抗原的联检试纸及其制备方法 | |
CN202794178U (zh) | 降钙素原快速定量免疫层析检测试剂盒 | |
CN104422772B (zh) | 一种定量检测胃蛋白酶原i的时间分辨免疫层析试纸条及其制备方法 | |
CN113009153B (zh) | 一种基于磁微粒化学发光的新冠病毒中和抗体检测试剂盒及其应用 | |
CN109991409B (zh) | 胃蛋白酶原i/胃蛋白酶原ii检测试剂盒 | |
CN104316702A (zh) | Pct 与crp定量联检层析试纸条及其制备方法 | |
EP3076177B1 (en) | Immunochromatography-assisted detection method | |
CN112305218A (zh) | 一种新型冠状病毒抗体胶体金免疫侧向层析检测方法及其应用 | |
CN205333641U (zh) | 一种pct时间分辨荧光纳米免疫层析定量检测试纸条 | |
CN202433383U (zh) | 一种甲型流感病毒抗原和乙型流感病毒抗原的联检试纸 | |
CN102539755A (zh) | 一种检测分泌物中甲型流感病毒抗原的试纸条及其制备方法 | |
CN101368954A (zh) | 利用唾液进行临床或非临床检测艾滋病病毒的装置与方法 | |
CN107727855B (zh) | 用于检测尿液中hiv抗体的样品垫、样品垫处理液及试纸条 | |
CN204964520U (zh) | 一种用于快速检测病毒抗体的检测卡 | |
CN202141725U (zh) | 一种定性/定量检测乙型肝炎病毒表面抗原的磁珠免疫层析试剂盒 | |
CN102109526B (zh) | 草鱼呼肠孤病毒快速检测试纸及其制备、使用方法 | |
CN106053783A (zh) | 一种适用于结核感染t细胞检测的快速时间分辨荧光免疫分析试剂盒及其检测方法 | |
CN107957497A (zh) | 一种禽流感h5亚型病毒抗体快速定量检测试剂盒及其应用 | |
CN115267208B (zh) | 一种幽门螺旋杆菌抗体检测用抗原、试剂盒及其制备方法 | |
CN107727856B (zh) | 检测尿液中hiv抗体的试纸条、检测线包被液及其制备方法 | |
CN106290863A (zh) | 一种人类丙肝病毒(hcv)唾液/尿液抗体胶体金检测试剂盒及其制备方法 | |
CN102435732A (zh) | 弓形虫IgM抗体免疫印迹试剂盒及其制备方法 | |
CN103913568A (zh) | 一种人体自身抗体联检试纸条及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 510530 litchi mountain road 8, Luogang District Science City, Guangdong, Guangzhou Applicant after: GUANGZHOU WONDFO BIOTECH Co.,Ltd. Address before: 510530 litchi mountain road 8, Luogang District Science City, Guangdong, Guangzhou Applicant before: GUANGZHOU WONDFO BIOTECH. Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: GUANGZHOU WONDOFO BIOMEDICAL CO., LTD. TO: GUANGZHOU WONDFO BIOTECH. CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20110112 Assignee: Guangzhou Kaide Finance Leasing Co.,Ltd. Assignor: GUANGZHOU WONDFO BIOTECH Co.,Ltd. Contract record no.: 2019990000218 Denomination of invention: Test strip for detecting HIV antibodies in spittle and preparation method thereof Granted publication date: 20130403 License type: Exclusive License Record date: 20190709 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Test strip for detecting HIV antibodies in spittle and preparation method thereof Effective date of registration: 20190807 Granted publication date: 20130403 Pledgee: Guangzhou Kaide Finance Leasing Co.,Ltd. Pledgor: GUANGZHOU WONDFO BIOTECH Co.,Ltd. Registration number: Y2019990000035 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Guangzhou Kaide Finance Leasing Co.,Ltd. Assignor: GUANGZHOU WONDFO BIOTECH Co.,Ltd. Contract record no.: 2019990000218 Date of cancellation: 20220922 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220922 Granted publication date: 20130403 Pledgee: Guangzhou Kaide Finance Leasing Co.,Ltd. Pledgor: GUANGZHOU WONDFO BIOTECH Co.,Ltd. Registration number: Y2019990000035 |